Harel Insurance's venture capital arm, primarily through its Harel Tech entity, focuses on direct investments in early-stage, growth-stage, and later-stage technology startups. Their strategy emphasizes areas such as Fintech, Med Tech (including digital health and biotech), Telecom & Media Software, Data Centers, and alternative energy, with a recent pivot towards AI-related technology investments.
33% of their portfolio is in Insurance. Their most common stage is series-b (67% of deals). Average disclosed round size is $192.6M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Assured Allies | Series B | $42.5M | Mar 2023 |
 Eikon Therapeutics | Series B | $517.8M | Jan 2022 |
 Quantum Machines | Series A | $17.5M | Mar 2020 |
Top Co-Investors
FinTLV1 shared
Lumir1 shared
Hamilton Lane1 shared
New Era Capital Partners1 shared
MS&AD Ventures1 shared
Core Innovation Ventures1 shared
Poalim Equity1 shared
Samsung Next1 shared
Lux Capital1 shared
T. Rowe Price1 shared
General Catalyst1 shared
UC Investments1 shared
Abu Dhabi Investment Authority1 shared
Stepstone1 shared
Soros Fund Management1 shared
Schroders Capital1 shared
AME Cloud1 shared
The Column Group1 shared
Foresite Capital1 shared
Last updated: 7 April 2026